The management of superficial transitional cell carcinoma of the bladder

Shomik Sengupta, Michael L. Blute, H. Barton Grossman, Louis S. Liou, Victor E. Reuter, Mark S. Soloway, J. Stephen Jones

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Superficial transitional cell carcinomas (TCC) of the urinary bladder, defined as those that are restricted to the mucosa or the lamina propria, represent a common condition with a wide spectrum of biologic significance. High-grade superficial TCC, particularly in the presence of lamina propria invasion, has a significant risk of occult or subsequent progression to muscle-invasive or metastatic disease. Such high-risk lesions merit aggressive therapy with repeat resection followed by intravesical therapy, usually in the form of bacille Calmette-Guérin. Criteria for failure of intravesical therapy are not well defined, but persistent cytologic or cystoscopic abnormalities at 6 months are worrisome. Salvage intravesical therapy may sometimes be successful, but early cystectomy should be strongly considered, especially in younger patients. Close surveillance of patients with high-risk superficial TCC is essential.

Original languageEnglish
Pages (from-to)48-55
Number of pages8
JournalUrology
Volume67
Issue number3 SUPPL. 1
DOIs
StatePublished - Mar 1 2006
Externally publishedYes

Fingerprint

Transitional Cell Carcinoma
Mucous Membrane
Urinary Bladder
Salvage Therapy
Cystectomy
Therapeutics
Muscles

ASJC Scopus subject areas

  • Urology

Cite this

Sengupta, S., Blute, M. L., Grossman, H. B., Liou, L. S., Reuter, V. E., Soloway, M. S., & Jones, J. S. (2006). The management of superficial transitional cell carcinoma of the bladder. Urology, 67(3 SUPPL. 1), 48-55. https://doi.org/10.1016/j.urology.2006.01.041

The management of superficial transitional cell carcinoma of the bladder. / Sengupta, Shomik; Blute, Michael L.; Grossman, H. Barton; Liou, Louis S.; Reuter, Victor E.; Soloway, Mark S.; Jones, J. Stephen.

In: Urology, Vol. 67, No. 3 SUPPL. 1, 01.03.2006, p. 48-55.

Research output: Contribution to journalArticle

Sengupta, S, Blute, ML, Grossman, HB, Liou, LS, Reuter, VE, Soloway, MS & Jones, JS 2006, 'The management of superficial transitional cell carcinoma of the bladder', Urology, vol. 67, no. 3 SUPPL. 1, pp. 48-55. https://doi.org/10.1016/j.urology.2006.01.041
Sengupta S, Blute ML, Grossman HB, Liou LS, Reuter VE, Soloway MS et al. The management of superficial transitional cell carcinoma of the bladder. Urology. 2006 Mar 1;67(3 SUPPL. 1):48-55. https://doi.org/10.1016/j.urology.2006.01.041
Sengupta, Shomik ; Blute, Michael L. ; Grossman, H. Barton ; Liou, Louis S. ; Reuter, Victor E. ; Soloway, Mark S. ; Jones, J. Stephen. / The management of superficial transitional cell carcinoma of the bladder. In: Urology. 2006 ; Vol. 67, No. 3 SUPPL. 1. pp. 48-55.
@article{5574151dac0142298832b1196d2cf17e,
title = "The management of superficial transitional cell carcinoma of the bladder",
abstract = "Superficial transitional cell carcinomas (TCC) of the urinary bladder, defined as those that are restricted to the mucosa or the lamina propria, represent a common condition with a wide spectrum of biologic significance. High-grade superficial TCC, particularly in the presence of lamina propria invasion, has a significant risk of occult or subsequent progression to muscle-invasive or metastatic disease. Such high-risk lesions merit aggressive therapy with repeat resection followed by intravesical therapy, usually in the form of bacille Calmette-Gu{\'e}rin. Criteria for failure of intravesical therapy are not well defined, but persistent cytologic or cystoscopic abnormalities at 6 months are worrisome. Salvage intravesical therapy may sometimes be successful, but early cystectomy should be strongly considered, especially in younger patients. Close surveillance of patients with high-risk superficial TCC is essential.",
author = "Shomik Sengupta and Blute, {Michael L.} and Grossman, {H. Barton} and Liou, {Louis S.} and Reuter, {Victor E.} and Soloway, {Mark S.} and Jones, {J. Stephen}",
year = "2006",
month = "3",
day = "1",
doi = "10.1016/j.urology.2006.01.041",
language = "English",
volume = "67",
pages = "48--55",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3 SUPPL. 1",

}

TY - JOUR

T1 - The management of superficial transitional cell carcinoma of the bladder

AU - Sengupta, Shomik

AU - Blute, Michael L.

AU - Grossman, H. Barton

AU - Liou, Louis S.

AU - Reuter, Victor E.

AU - Soloway, Mark S.

AU - Jones, J. Stephen

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Superficial transitional cell carcinomas (TCC) of the urinary bladder, defined as those that are restricted to the mucosa or the lamina propria, represent a common condition with a wide spectrum of biologic significance. High-grade superficial TCC, particularly in the presence of lamina propria invasion, has a significant risk of occult or subsequent progression to muscle-invasive or metastatic disease. Such high-risk lesions merit aggressive therapy with repeat resection followed by intravesical therapy, usually in the form of bacille Calmette-Guérin. Criteria for failure of intravesical therapy are not well defined, but persistent cytologic or cystoscopic abnormalities at 6 months are worrisome. Salvage intravesical therapy may sometimes be successful, but early cystectomy should be strongly considered, especially in younger patients. Close surveillance of patients with high-risk superficial TCC is essential.

AB - Superficial transitional cell carcinomas (TCC) of the urinary bladder, defined as those that are restricted to the mucosa or the lamina propria, represent a common condition with a wide spectrum of biologic significance. High-grade superficial TCC, particularly in the presence of lamina propria invasion, has a significant risk of occult or subsequent progression to muscle-invasive or metastatic disease. Such high-risk lesions merit aggressive therapy with repeat resection followed by intravesical therapy, usually in the form of bacille Calmette-Guérin. Criteria for failure of intravesical therapy are not well defined, but persistent cytologic or cystoscopic abnormalities at 6 months are worrisome. Salvage intravesical therapy may sometimes be successful, but early cystectomy should be strongly considered, especially in younger patients. Close surveillance of patients with high-risk superficial TCC is essential.

UR - http://www.scopus.com/inward/record.url?scp=33644783750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644783750&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2006.01.041

DO - 10.1016/j.urology.2006.01.041

M3 - Article

C2 - 16530076

AN - SCOPUS:33644783750

VL - 67

SP - 48

EP - 55

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3 SUPPL. 1

ER -